Elisabeth Rosenthal on Muck Rack

Elisabeth Rosenthal

Washington, D.C.
As seen in: KFF Health News, LinkedIn, CNN, Medium, MSN, The New York Times, The New York Times en Español, The New York Times Magazine, Bloomberg News, Bloomberg Opinion, Nature and
Sr. Contrib. Ed. @KFFHealthNews. MD. NYT. OpEd Writer. Bestselling Author. Prizes: Loeb, ONA, Elliott, etc. On list of "most influential people" in DC. Really?
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Elisabeth

Contact Elisabeth, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Try These Tips When You Can’t Afford Your Rx

|
By Elisabeth Rosenthal, Louis Jacobson Verified
| KFF Health News Verified
Last year, An Arm and a Leg set out on a mission: Collect the best advice about what to do when you can’t afford your prescription drugs. Dozens of listeners wrote in.
Open in Who Shared Issue with article?

Trump promised cheaper drugs. Some prices dropped. Many others shot up.

|
By Elisabeth Rosenthal
| Miami Herald Verified
President Donald Trump announces the launch of the TrumpRx website on Feb. 5, 2026. Since his second term started, President Donald Trump has announced, negotiated, or floated a flurry of initiatives aimed at taming the excesses of the pharmaceutical industry. No surprise. About are “worried about being able to afford prescription drug costs for themselves or their families,” a recent KFF nationwide poll showed.
Open in Who Shared View Duplicates (80) Issue with article?

Trump promised cheaper drugs. Some prices dropped. Many others shot up

|
By Elisabeth Rosenthal, Arthur Allen Verified, Sadie Harley
| Medical Xpress Verified
Since his second term started, President Donald Trump has announced, negotiated or floated a flurry of initiatives aimed at taming the excesses of the pharmaceutical industry. No surprise. About are "worried about being able to afford prescription drug costs for themselves or their families," a recent KFF nationwide poll showed. More than 80% consider the price of prescription drugs "unreasonable," and most support increased regulation to lower costs.
Open in Who Shared Issue with article?
See all 2,725 licensed articles (2,928 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified